ArticleeNeurologicalSci2026
Nitrous oxide-related neurotoxicity: Clinical features, key investigations, and a proposed diagnostic approach from a single-center cohort.
Article in eNeurologicalSci, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Recreational use of nitrous oxide (N Methods: We conducted a retrospective study of 52 consecutive patients diagnosed with N Results: The median age was 24.0 [21.8;28.0] years, with a female-to-male ratio of 1.7:1. Acute onset (< 4 weeks) was observed in 61.5% of cases. Sensory symptoms occurred in 94.2% and gait ataxia in 86.5%, with 88.5% exhibited a pattern of distal weakness exceeding proximal. Elevated homocysteine was present in 43 (89.6%), whereas low total B12 was found in only 10.4%. MRI abnormalities were detected in 31/48 (64.6%), with the "inverted V" sign in 17 cases (54.8%). Reduced CMAPS with intact sensory potentials was the most common EDX pattern 17 (32.7%), and needle electromyography showed ongoing denervation in 66%. Exploratory association analyses did not identify any significant relationships between EDX classifications, MRI findings, symptom onset, or homocysteine levels. Conclusion: Nitrous oxide neurotoxicity is characterized by predominant sensory symptoms, gait ataxia and elevated homocysteine. EDX patterns are heterogenous and non-specific. A combined approach using spinal MRI, serum homocysteine and EDX could play a key role in differentiating this pathology from other mimickers and achieving a timely and accurate diagnosis.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.